Portfolio (Quarterly)
Guide ↗
Avoro Capital Advisors LLC
· CIK 0001633313| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | UTHR | UNITED THERAPEUTICS CORP | Healthcare | 2,630,000.0 | $1.56B | 15.34% | +24K | +0.9% | $592.98 | -6.4% |
| 2 | — | ASCENDIS PHARMA | — | 5,062,500.0 | $1.16B | 11.39% | -49K | -0.9% | $228.73 | — |
| 3 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 1,818,181.0 | $951.8M | 9.36% | +11K | +0.6% | $523.47 | -4.5% |
| 4 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 2,888,888.0 | $746.3M | 7.34% | — | — | $258.32 | +33.6% |
| 5 | ARGX | ARGENX SE | Healthcare | 1,000,000.0 | $730.2M | 7.18% | +10K | +1.0% | $730.25 | +23.2% |
| 6 | ARWR | ARROWHEAD PHARMACEUTICALS INC | Healthcare | 10,699,999.0 | $670.9M | 6.60% | +75K | +0.7% | $62.70 | +31.0% |
| 7 | KYMR | KYMERA THERAPEUTICS INC | Healthcare | 7,474,747.0 | $622.6M | 6.12% | — | — | $83.29 | +8.5% |
| 8 | APLS | APELLIS PHARMACEUTICALS INC | Healthcare | 12,222,222.0 | $491.7M | 4.84% | — | — | $40.23 | +2.0% |
| 9 | CNTA | CENTESSA PHARMACEUTICALS PLC | Healthcare | 11,430,455.0 | $454.0M | 4.47% | -3.1M | -21.5% | $39.72 | +0.2% |
| 10 | CELC | CELCUITY INC | Healthcare | 3,375,000.0 | $385.2M | 3.79% | +264K | +8.5% | $114.14 | -23.3% |
| 11 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 5,777,777.0 | $336.0M | 3.31% | +353K | +6.5% | $58.15 | -8.2% |
| 12 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 6,555,555.0 | $316.0M | 3.11% | — | — | $48.20 | -6.7% |
| 13 | TERN | TERNS PHARMACEUTICALS INC | Healthcare | 5,695,000.0 | $300.2M | 2.95% | +1.3M | +30.9% | $52.72 | +0.4% |
| 14 | VERA | VERA THERAPEUTICS INC | Healthcare | 5,888,888.0 | $236.9M | 2.33% | — | — | $40.23 | -11.9% |
| 15 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 2,344,444.0 | $228.0M | 2.24% | +174K | +8.0% | $97.25 | +65.2% |
| 16 | CYTK | CYTOKINETICS INC | Healthcare | 3,333,333.0 | $219.7M | 2.16% | NEW | — | $65.91 | +20.0% |
| 17 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 12,315,000.0 | $104.3M | 1.03% | +1.5M | +14.3% | $8.47 | +12.9% |
| 18 | — | DAMORA THERAPEUTICS INC | — | 3,783,000.0 | $98.0M | 0.96% | NEW | — | $25.90 | — |
| 19 | QURE | UNIQURE NV | Healthcare | 5,959,595.0 | $97.4M | 0.96% | -190K | -3.1% | $16.35 | +189.3% |
| 20 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 21,700,000.0 | $97.0M | 0.95% | — | — | $4.47 | +41.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%